FDA Import Refusal AEK-8219975-1/11/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment AEK-8219975-1/11/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Feb 13, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 13, 2025
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118